Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells
Authors
Keywords
-
Journal
BLOOD
Volume 118, Issue 5, Pages 1329-1339
Publisher
American Society of Hematology
Online
2011-06-10
DOI
10.1182/blood-2011-01-327197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endogenous Noxa Determines the Strong Proapoptotic Synergism of the BH3-Mimetic ABT-737 with Chemotherapeutic Agents in Human Melanoma Cells
- (2014) Arnim Weber et al. Translational Oncology
- BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists
- (2009) K C Goldsmith et al. CELL DEATH AND DIFFERENTIATION
- The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteins
- (2009) Delphine Mérino et al. JOURNAL OF CELL BIOLOGY
- Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1
- (2009) S. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737
- (2009) P. Hauck et al. MOLECULAR CANCER THERAPEUTICS
- ABT-737 Synergizes with Chemotherapy to Kill Head and Neck Squamous Cell Carcinoma Cells via a Noxa-Mediated Pathway
- (2009) R. Li et al. MOLECULAR PHARMACOLOGY
- Mimicking the BH3 domain to kill cancer cells
- (2009) T Ni Chonghaile et al. ONCOGENE
- RNA Silencing of Mcl-1 Enhances ABT-737-Mediated Apoptosis in Melanoma: Role for a Caspase-8-Dependent Pathway
- (2009) Angela M. Keuling et al. PLoS One
- BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma
- (2008) A. A. Morales et al. BLOOD
- Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors
- (2008) K. F. Whitecross et al. BLOOD
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer
- (2008) C. L. Hann et al. CANCER RESEARCH
- Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-xL Inhibitor, ABT-737
- (2008) K. Okumura et al. CLINICAL CANCER RESEARCH
- Involvement of BH3-only proteins in hematologic malignancies
- (2008) Junya Kuroda et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Identification of the Major Phosphorylation Site in Bcl-xL Induced by Microtubule Inhibitors and Analysis of Its Functional Significance
- (2008) Meenakshi Upreti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: Signaling pathway interactions
- (2008) Anna S. Garza et al. LEUKEMIA RESEARCH
- Multisite Phosphorylation Regulates Bim Stability and Apoptotic Activity
- (2008) Anette Hübner et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started